Dorsey Wright & Associates
- SEC CIK
- 0001376772
- Latest filing
- Aug 6, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Dorsey Wright & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −62,128−100.0% | Sold out | Holders |
| Q3 2024 | 62,128 | $7.40M | 1.8% | +7,543+13.8% | Added | Holders |
| Q2 2024 | 54,585 | $7.79M | 2.0% | −1,850−3.3% | Reduced | Holders |
| Q1 2024 | 56,435 | $7.25M | 1.9% | −3,334−5.6% | Reduced | Holders |
| Q4 2023 | 59,769 | $6.18M | 1.9% | −4,644−7.2% | Reduced | Holders |
| Q3 2023 | 64,413 | $5.86M | 1.8% | −4,139−6.0% | ReducedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 34,276 | $5.55M | 1.7% | −3,444−9.1% | Reduced | Holders |
| Q1 2023 | 37,720 | $6.00M | 1.8% | −2,512−6.2% | Reduced | Holders |
| Q4 2022 | 40,232 | $5.44M | 1.6% | – | No prior filing | Holders |
| Q3 2022 | – | – | – | – | Not filed | Holders |
| Q2 2022 | 44,706 | $4.98M | 1.5% | −5,318−10.6% | Reduced | Holders |
| Q1 2022 | 50,024 | $5.55M | 1.3% | −1,503−2.9% | Reduced | Holders |
| Q4 2021 | 51,527 | $5.77M | 1.2% | +1,013+2.0% | Added | Holders |
| Q3 2021 | 50,514 | $4.85M | 1.1% | +50,514 | New | Holders |